NEXT
Sign in to follow

The Legal Intelligencer

SCOTUS: Preemption in Failure-to-Warn Cases a Question for Judges, Not Juries

In a win for Big Pharma, the U.S. Supreme Court on Monday remanded a class of failure-to-warn tort claims against drug manufacturer Merck to the U.S. Court of Appeals for the Third Circuit for determination by judges, not juries.
4 minute read

Litigation Daily

Pelvic Mesh Plaintiff Secures $80M Verdict Against J&J Subsidiary From Phila. Jury

A Philadelphia jury has awarded more than $80 million to a woman who claimed a pelvic mesh device developed by a Johnson & Johnson subsidiary eroded and caused injury.
3 minute read

The Legal Intelligencer

Pelvic Mesh Plaintiff Secures $80M Verdict From Phila. Jury Against J&J Subsidiary

A Philadelphia jury has awarded more than $80 million to a woman who claimed a pelvic mesh device developed by a Johnson & Johnson subsidiary eroded and caused injury.
3 minute read

The Legal Intelligencer

Statute of Limitations That Could End 40% of Pa. Risperdal Cases Is Weighed by High Court

The Pennsylvania Supreme Court on Thursday probed into questions about what level of public awareness regarding the dangers of a widely used pharmaceutical can sufficiently put potential plaintiffs on notice to investigate their claims.
4 minute read

The Recorder

Gilead Accusers Say Supreme Court Has Changed the Game on Licensing

Durie Tangri's Mark Lemley, an attorney for a would-be class of consumers and insurers, says a 2015 ruling on a Spider-Man toy established limits on royalties that drug companies are ignoring.
5 minute read

Litigation Daily

Gilead Accusers Argue Supreme Court Has Changed the Game on Licensing

Durie Tangri's Mark Lemley, an attorney for a would-be class of consumers and insurers, says a 2015 ruling on a Spider-Man toy established limits on royalties that drug companies are ignoring.
5 minute read

Litigation Daily

AbbVie, Boehringer Settle Humira Patent Fight

Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.
3 minute read

Delaware Business Court Insider

AbbVie, Boehringer Settle Humira Patent Dispute in U.S.

Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.
3 minute read

The Legal Intelligencer

Pa. AG Sues OxyContin Maker Purdue Pharma Over Opioid Epidemic

Accusing the manufacturer of the painkiller OxyContin of sparking the opioid epidemic in the Keystone State, Pennsylvania Attorney General Josh Shapiro has filed a lawsuit against Purdue Pharma.
4 minute read

New York Law Journal

Columbia Law School Professor Joins Life Biosciences as General Counsel

Amit Shashank, a lecturer in law at Columbia Law who had a stint as a corporate attorney at Shearman & Sterling, joins Boston-based Life Biosciences after having served as executive vice president, general counsel and secretary of global design and engineering company Aricent.
3 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025

    Brought to you by Erase.com

    Download Now

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now